Treatment Of Uterine Myomas Research Articles

Relationship between gonadotropin-releasing hormone agonist and myoma cellular activity: preliminary findings on positron emission tomography

Uterine myomas generally develop in women during their childbearing years. Nonsurgical treatment of uterine myoma has focused primarily on use of the GnRH agonist, which produces temporary menopause. However, clinical application of GnRH agonist therapy has been limited because uterine volume often increases after discontinuation of treatment, insufficient volume reduction is achieved in some patients, and most leiomyomas return to their pretreatment size after cessation of treatment.

Ovarian Failure after Uterine Artery Embolization for Treatment of Myomas

Uterine artery embolization (UAE) is an effective, safe, nonsurgical treatment for uterine myomas. Although menstrual irregularities and transient amenorrhea have occurred after UAE, these reports did not provide proper hormonal documentation of ovarian failure. Our patient experienced elevated follicle-stimulating hormone (FSH) levels and vasomotor symptoms (hot flushes) within 4 weeks after the procedure. To our knowledge, this is the first report in the literature of ovarian failure after UAE confirmed by comparing preprocedure FSH levels with postprocedure levels over 12 months.

Uterine artery embolization for the treatment of uterine myomas: Preliminary results

Uterine artery embolization for the treatment of uterine myomas: Preliminary results

Operative treatment of uterine myomas in pregnancy

Operative treatment of uterine myomas in pregnancy

Evaluation of various therapeutic modalities in treatment of uterine myomas

Evaluation of various therapeutic modalities in treatment of uterine myomas

Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient

The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successful treatment of uterine myomas with menorrhagia in a woman with a renal transplant. There was a significant reduction in menorrhagia, dysmenorrhea, and uterine and myoma size with the use of the LNG-IUS. We believe that this system provides an alternative to conventional hysterectomy and gonadotrophin-releasing hormonal analog medical treatment for uterine myomas, with a possibly inhibitory effect on myoma growth.

Endoscopic management of uterine myoma.

This study was undertaken to evaluate the various gynecologic endoscopic surgical techniques including resectoscopic myomectomy, laparoscopic myomectomy, and laparoscopy assisted vaginal hysterectomy (LAVH) used in the treatment of uterine myomas. The medical records of 136 cases of uterine myomas treated using one or more of the gynecologic endoscopic surgical techniques in the Department of Obstetrics and Gynecology at Yonsei University were retrospectively reviewed from March 1997 to September 1998. Of the 136 cases reviewed, there were 40 submucosal myomas and 96 intramural and subserosal myomas. For statistical analysis, Student's t-test was used. Submucosal myomectomy using the resectosope was performed in 35 cases (mean age: 39 +/- 1.5 years), laparoscopic myomecotmy in 35 cases (mean age: 36 +/- 1.9 years), and LAVH in 66 cases (mean age: 42 +/- 1.1 years). In cases of huge myomas, the GnRH agonist was used prior to surgery, and in cases of heavy uterine bleeding, angioblock of the uterine artery was undertaken before the endoscopic procedures. The mean operating time was significantly shorter in resectoscopic myomectomy (41 +/- 12 min), followed by laparoscopic myomectomy (85.0 +/- 10.3 min) and LAVH (123 +/- 5.3 min). The mean hospital stay for resectoscopic myomectomy, laparoscopic myomectomy, and LAVH was 1.9 +/- 0.5, 2.5 +/- 0.5, and 3.4 +/- 0.8 days (p < 0.001), respectively. There were 3 cases of complications including pulmonary edema and uterine perforation in the resectoscopic myomectomy group, and 4 cases of complications including bladder, ureter, and epigastric vessel injury in the LAVH group. In conclusion, the therapeutic effect of various gynecologic endoscopic surgical techniques can be maximized in terms of shorter operation time, shorter hospital stay, faster recovery, and less blood loss by the appropriate management of uterine myoma in well-chosen patients.

Effect of GnRH Agonist in the Treatment of Uterine Myoma

Effect of GnRH Agonist in the Treatment of Uterine Myoma

The effect of GnRH-analogue for the treatment of uterine myoma

The effect of GnRH-analogue for the treatment of uterine myoma

El tratamiento de los miomas uterinos (1876-1936). Una controversia profesional entre cirujanos y radiólogos

A lo largo del proceso de constitución de la radioterapia como especialidad médica diversas polémicas fueron enfrentando a dermatólogos, ginecólogos, otorrinos y radioterapéutas por el monopolio del tratamiento con radiaciones. En el presente trabajo abordamos un aspecto de la negociación que fue configurando la conducta terapéutica frente a los miomas del útero.

Treatment of Uterine Myomas with GnRH Agonists

Treatment of Uterine Myomas with GnRH Agonists

Abdominal myomectomy in the treatment of uterine myomas

1.1. Two hundred and six consecutive cases of abdominal myomectomy are presented.2.2. Review of the literature confirms that postoperative morbidity and later recurrence are the main sources of criticism of this operation.3.3. The high incidence of pelvic infection, of common-law marriage, and of the desire for conservation was discussed.4.4. Details of operative technique were described with particular reference to opening the uterine cavity as a routine.5.5. The present low rate of recurrence was commented upon.6.6. A plea was made for the greater use of the operation of abdominal myomectomy.

The Surgical Treatment of Uterine Myomas in the Young Woman

The Surgical Treatment of Uterine Myomas in the Young Woman

Current issues in obstetrics and gynecology in 1893

The author informs him of the latest data, gleaned from the literature, on inflammatory diseases of the uterine appendages and their treatment (Schauta, Terria, Hartmann, Martin, Gonlliond, Doyen) and on the operative treatment of uterine myomas (Gottschalk, Kstner, Gauhrobak, Zifwe, Ott).

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma

The Modern Treatment of Uterine Myoma